Moore Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,117	Closed	-$308K	–	447
2023 Q2	$308K	Buy	+17,117	New	+$308K	0.01%	323